Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics

NCT05033119 is registered in ClinicalTrials.gov with Ulla Schierup Nielsen as lead sponsor.

NCT NCT05033119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05033119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
Lead sponsor
Ulla Schierup Nielsen
Phase
Observational
Overall status
Completed
Start date
November 1, 2021
Completion date
December 31, 2024
Enrollment
90 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

antipsychotics and neuroleptics toxicity, growth disorders, hyperprolactinemia, metabolic syndrome, puberty disorders